- 米国企業
- Coherus BioSciences, Inc.
Coherus BioSciences, Inc.CHRS
| 2014年 12月31日 | 2015年 12月31日 | 2016年 12月31日 | 2017年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 |
---|
Cash and cash equivalents | 150 | 158 | 125 | 127 | 72 | 178 | 541 | 417 | 64 |
---|
Marketable Securities, Current | - | - | - | - | - | - | - | - | 128 |
---|
Trade receivables, net | - | - | - | - | - | 142 | 157 | 123 | 110 |
---|
Inventory | - | - | - | - | 2 | 10 | 44 | 38 | 39 |
---|
Prepaid manufacturing | - | - | - | - | 8 | 9 | 19 | 14 | 18 |
---|
Other prepaids and current assets | - | - | - | - | - | 5 | 6 | 11 | 23 |
---|
Total current assets | 179 | 197 | 161 | 145 | 84 | 343 | 767 | 602 | 381 |
---|
Property and equipment, net | 4 | 11 | 11 | 13 | 7 | 6 | - | 8 | 9 |
---|
Inventory Noncurrent | - | - | - | - | 4 | 45 | 48 | 56 | 76 |
---|
Goodwill and intangible assets | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 6 |
---|
Other Assets Noncurrent | 0 | 0 | 2 | 0 | 0 | 0 | 2 | 10 | 9 |
---|
Total assets | 187 | 212 | 178 | 163 | 99 | 409 | 842 | 679 | 481 |
---|
Accounts payable | 9 | 26 | 20 | 15 | 15 | 26 | 15 | 16 | 12 |
---|
Accrued rebates, fees and reserves | - | - | - | - | - | 51 | 82 | 79 | 54 |
---|
Accrued compensation | - | - | - | - | 11 | 18 | 22 | 22 | 23 |
---|
Accrued Liabilities Current | 11 | 24 | 28 | 9 | 7 | 17 | 23 | 48 | 50 |
---|
Total current liabilities | 52 | 106 | 56 | 28 | 33 | 115 | 146 | 165 | 139 |
---|
Term loans | - | - | - | - | - | - | - | - | 245 |
---|
Convertible notes | - | - | - | - | - | - | 223 | 224 | 226 |
---|
Lease liabilities, non-current | - | - | - | - | - | - | 10 | 7 | 5 |
---|
Other Liabilities Noncurrent | 0 | 2 | 2 | 2 | 2 | - | 1 | 1 | 3 |
---|
Total liabilities | 120 | 219 | 159 | 132 | 138 | 304 | 561 | 582 | 618 |
---|
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
---|
Additional paid-in capital | - | - | - | - | - | - | 1,044 | 1,148 | 1,204 |
---|
Accumulated other comprehensive loss | -1 | -0 | -1 | -1 | -0 | -1 | -0 | -0 | -0 |
---|
Accumulated deficit | -187 | -410 | -537 | -775 | -985 | -895 | -763 | -1,050 | -1,342 |
---|
Total stockholders' equity (deficit) | 67 | -6 | 21 | 32 | -39 | 105 | 281 | 98 | -137 |
---|
Total liabilities and stockholders' equity (deficit) | 187 | 212 | 178 | 163 | 99 | 409 | 842 | 679 | 481 |
---|